Sri Lanka, Dec. 18 -- Health Services Director General Dr. Asela Gunawardena stated that Health authorities have launched investigations into two deaths reported at the Infectious Diseases Hospital (IDH), and stressed that it has not yet been conclusively established that the incidents were caused by the drug Ondansetron.

NMRA Chairman Dr. Ananda Wijewickrama stated that on December 12, following information received indicating possible contamination in the drug, immediate steps were taken to temporarily withdraw all categories of the questionable drug Ondansetron from its use on patients.

Addressing a special media briefing held yesterday (17) at the Department of Government Information, he stated that there is no need for the public t...